Abstract Purpose of Review Monogenic forms of diabetes have specific treatments that differ
from the standard care provided for type 1 and type 2 diabetes, making the appropriate …

Monogenic diabetes represents a heterogeneous group of disorders resulting from defects
in single genes. Defects are categorized primarily into two groups: disruption of β‐cell …

Single gene mutations that primarily affect pancreatic β-cell function account for
approximately 1–2% of all cases of diabetes. Overlapping clinical features with common …

Individualization of therapy based on a person's specific type of diabetes is one key element
of a “precision medicine” approach to diabetes care. However, applying such an approach …

Monogenic diabetes refers to diabetes mellitus (DM) caused by a mutation in a single gene
and accounts for approximately 1%–5% of diabetes. Correct diagnosis is clinically critical for …

Abstract Aims/Introduction Monogenic diabetes accounts for approximately 1–2% of all
diabetes, and is difficult to distinguish from type 1 and type 2 diabetes. Molecular diagnosis …

Aims/hypothesis Current genetic tests for diagnosing monogenic diabetes rely on selection
of the appropriate gene for analysis according to the patient's phenotype. Next-generation …

Monogenic diabetes consists of different subtypes of single gene disorders comprising a
large spectrum of phenotypes, namely neonatal diabetes mellitus or monogenic diabetes of …

Type 2 diabetes represents a major and increasing contributor to morbidity and mortality
worldwide. Of the world′ s population, 10% either have Type 2 diabetes, or will develop it …

Background Monogenic diabetes presents opportunities for precision medicine but is
underdiagnosed. This review systematically assessed the evidence for (1) clinical criteria …